Standardization of coding definitions for sickle cell disease complications: A systematic literature review

被引:0
|
作者
Ericksen, Paulette Negron [1 ]
Dabbous, Firas [2 ]
Ghosh, Rajrupa [2 ]
Shah, Surbhi [2 ]
Sun, Xunming [1 ]
Meier, Emily Riehm [1 ]
Colavecchia, Carmine [1 ]
机构
[1] Pfizer Inc, New York, NY 10001 USA
[2] Evidera, Data Analyt Real World Evidence, Bethesda, MD USA
关键词
comorbidities; complications; diagnosis codes; real-world evidence; sickle cell disease; systematic literature review; ACUTE CHEST SYNDROME; RISK-FACTORS; CLINICAL-OUTCOMES; UNITED-STATES; MORTALITY; ASSOCIATION; US; PREVALENCE; MANAGEMENT; CHILDREN;
D O I
10.1002/pds.5769
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PurposeSickle cell disease (SCD) affects all organ systems and is characterized by numerous acute and chronic complications and comorbidities. Standardized codes are needed for complications/comorbidities used in real-world evidence (RWE) studies that rely on administrative and medical coding. This systematic literature review was conducted to produce a comprehensive list of complications/comorbidities associated with SCD, along with their diagnosis codes used in RWE studies.MethodsA search in MEDLINE and Embase identified studies published from 2016 to 2023. Studies were included if they were conducted in US SCD populations and reported complications/comorbidities and respective International Classification of Diseases, Clinical Modification (ICD-CM) codes. All identified complications/comorbidities and codes were reviewed by a certified medical coding expert and hematologist.ResultsOf 1851 identified studies, 39 studies were included. The most reported complications/comorbidities were stroke, acute chest syndrome, pulmonary embolism, venous thromboembolism, and vaso-occlusive crisis. Most of the studies used ICD-9-CM codes (n = 21), while some studies used ICD-10-CM codes (n = 3) or both (n = 15), depending on the study period. Most codes reported in literature were heterogeneous across complications/comorbidities. The medical coding expert and hematologist recommended modifications for several conditions.ConclusionWhile many studies we identified did not report their codes and were excluded from this review, the studies with codes exhibited diverse coding definitions. By providing a standardized set of diagnosis codes that were reported by studies and reviewed by a coding expert and hematologist, our review can serve as a foundation for accurately identifying complications/comorbidities in future research, and may reduce heterogeneity, enhance transparency, and improve reproducibility. Future efforts focused on validating these code lists are needed.
引用
收藏
页数:28
相关论文
共 50 条
  • [41] Pregnancy and sickle cell disease: A review of the current literature
    Boga, Can
    Ozdogu, Hakan
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 364 - 374
  • [42] Complementary and alternative medicine for children with sickle cell disease: A systematic review
    Alsabri, Mohammed
    Carfagnini, Christina
    Amin, Mody
    Castilo, Fiorella
    Lewis, Jeremy
    Ashkar, Mohammad
    Hamzah, Mohammed
    Mohamed, Nader
    Saker, Mohammed
    Mahgerefteh, Joseph
    Victor, Rosemarie St.
    Peichev, Mario
    Kupferman, Fernanda
    Viswanathan, Kusum
    BLOOD REVIEWS, 2023, 59
  • [43] Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management
    Ballas, Samir K.
    Kesen, Muge R.
    Goldberg, Morton F.
    Lutty, Gerard A.
    Dampier, Carlton
    Osunkwo, Ifeyinwa
    Wang, Winfred C.
    Hoppe, Carolyn
    Hagar, Ward
    Darbari, Deepika S.
    Malik, Punam
    SCIENTIFIC WORLD JOURNAL, 2012,
  • [44] A Systematic Review of Medication Adherence Interventions in Pediatric Sickle Cell Disease
    Shih, Sharon
    Cohen, Lindsey L.
    JOURNAL OF PEDIATRIC PSYCHOLOGY, 2020, 45 (06) : 593 - 606
  • [45] Sickle Cell Disease, a Review
    Tebbi, Cameron K.
    HEMATO, 2022, 3 (02): : 341 - 366
  • [46] Sickle Cell Disease: A Review
    Kavanagh, Patricia L.
    Fasipe, Titilope A.
    Wun, Ted
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (01): : 57 - 68
  • [47] Management of Acute Complications of Sickle Cell Disease
    Shamayeva, Sabina
    Morocco, Perry
    PEDIATRIC ANNALS, 2024, 53 (02): : e47 - e51
  • [48] The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis
    Musa, B. M.
    Galadanci, N. A.
    Coker, M.
    Bussell, S.
    Aliyu, M. H.
    ANNALS OF HEMATOLOGY, 2016, 95 (11) : 1757 - 1764
  • [49] Screening for sickle cell disease in newborns: a systematic review
    Runkel, Britta
    Klueppelholz, Birgit
    Rummer, Anne
    Sieben, Wiebke
    Lampert, Ulrike
    Bollig, Claudia
    Markes, Martina
    Paschen, Ulrike
    Angelescu, Konstanze
    SYSTEMATIC REVIEWS, 2020, 9 (01)
  • [50] Main Complications during Pregnancy and Recommendations for Adequate Antenatal Care in Sickle Cell Disease: A Literature Review
    Figueira, Camilla Olivares
    Surita, Fernanda Garanhani
    Fertrin, Kleber
    Nobrega, Guilherme de Moraes
    Costa, Maria Laura
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2022, 44 (06): : 593 - 601